文献速递肿瘤 PET/CT

儿童肿瘤患者延迟全身[18F]FDG PET/CT的剂量降低

Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [18F]FDG PET/CT.
PubMed 文献 · J Nucl Med · 2024-07-01

单中心前瞻性研究纳入18例符合标准的儿童肿瘤患者,在静脉注射4.07±0.49 MBq/kg [18F]FDG后120分钟行20分钟全身PET/CT,通过子采样模拟¼、⅛及更少计数重建以模拟剂量降低。结论认为延迟全身[18F]FDG PET/CT在儿童中降低剂量可行且不损失图像质量或病灶可见性,但为保持肿瘤摄取与病灶可见性,PET中心不应将注射活度降至0.5 MBq/kg以下。

要点

  • 18例患儿共识别113个恶性病灶,其中87.6%可定量。
  • 肝脏SUVmean无显著变化,但所有低计数重建的信噪比均低于参考标准(P<0.0001)。
  • 作者指出,使用全身PET/CT在注射后120分钟行儿童显像时,注射活度不应低于0.5 MBq/kg。

核心结论

  • 儿童延迟[18F]FDG全身PET/CT降低剂量是可行的,不损失图像质量或病灶可见性。
  • 但为保持可比的肿瘤摄取和病灶可见性,PET中心在儿童注射后120分钟行全身PET/CT时不应将注射[18F]FDG活度降至0.5 MBq/kg以下。

研究设计与样本

  • 单中心前瞻性研究,儿童在静脉注射4.07±0.49 MBq/kg [18F]FDG后120分钟行20分钟全身PET/CT。
  • 利用全剂量列表模式参考标准采集(20分钟)计数的¼、⅛及更少计数生成5个随机子采样低计数重建以模拟剂量降低,对2个最低计数重建施加平滑。
  • 18例符合纳入标准的患者共识别113个恶性病灶,其中87.6%可定量。

主要发现

  • 肝脏SUVmean无显著变化,但所有低计数重建的信噪比均低于参考标准(P<0.0001),原因为噪声率更高。
  • 在计数为参考标准[公式见原文]和[公式见原文]的重建中,肿瘤摄取(SUVmax)、肿瘤-本底比和病灶总数显著低于参考标准(P<0.001)。
  • 所有低计数重建的对比噪声比和临床图像质量均显著低于参考标准。

关键数值与推荐

  • 背景摄取在升主动脉、肝右叶和第三腰椎椎体(L3)放置感兴趣体积测量。
  • 肿瘤病灶采用40%等轮廓感兴趣体积法分割。
  • 三名医师独立识别恶性病灶并使用5点Likert量表评估图像质量。

临床怎么用

  • 作者指出,使用全身PET/CT在儿童注射后120分钟行延迟[18F]FDG显像时,PET中心不应将注射活度降至0.5 MBq/kg以下。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our aim was to define a lower limit of reduced injected activity in delayed [18F]FDG total-body (TB) PET/CT in pediatric oncology patients. Methods: In this single-center prospective study, children were scanned for 20 min with TB PET/CT, 120 min after intravenous administration of a 4.07 ± 0.49 MBq/kg dose of [18F]FDG. Five randomly subsampled low-count reconstructions were generated using ¼, ⅛, [Formula: see text], and [Formula: see text] of the counts in the full-dose list-mode reference standard acquisition (20 min), to simulate dose reduction. For the 2 lowest-count reconstructions, smoothing was applied. Background uptake was measured with volumes of interest placed on the ascending aorta, right liver lobe, and third lumbar vertebra body (L3). Tumor lesions were segmented using a 40% isocontour volume-of-interest approach. Signal-to-noise ratio, tumor-to-background ratio, and contrast-to-noise ratio were calculated. Three physicians identified malignant lesions independently and assessed the image quality using a 5-point Likert scale. Results: In total, 113 malignant lesions were identified in 18 patients, who met the inclusion criteria. Of these lesions, 87.6% were quantifiable. Liver SUVmean did not change significantly, whereas a lower signal-to-noise ratio was observed in all low-count reconstructions compared with the reference standard (P < 0.0001) because of higher noise rates. Tumor uptake (SUVmax), tumor-to-background ratio, and total lesion count were significantly lower in the reconstructions with [Formula: see text] and [Formula: see text] of the counts of the reference standard (P < 0.001). Contrast-to-noise ratio and clinical image quality were significantly lower in all low-count reconstructions than with the reference standard. Conclusion: Dose reduction for delayed [18F]FDG TB PET/CT imaging in children is possible without loss of image quality or lesion conspicuity. However, our results indicate that to maintain comparable tumor uptake and lesion conspicuity, PET centers should not reduce the injected [18F]FDG activity below 0.5 MBq/kg when using TB PET/CT in pediatric imaging at 120 min after injection.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mingels C, Spencer BA, Nalbant H, et al. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [18F]FDG PET/CT. J Nucl Med. 2024. PMID: 38664017. doi:10.2967/jnumed.124.267521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。